Right Turn: Why Janet Rossant is optimistic about the future of regenerative medicine

Author: Stacey Johnson, 02/20/15


If you haven’t heard the name Janet Rossant, my guess is that you aren’t part of the stem cell community or you spend a little too much time in the lab.

Dr. Rossant is Chief of Research at the Hospital for Sick Children in Toronto, Canada and she leads the new Ontario Institute for Regenerative Medicine while also teaching at the University of Toronto. Last year she was the president of the International Society for Stem Cell Research (ISSCR). She is considered a world leader in developmental biology and her awards and accomplishments are too many to list here.

Dr. Rossant is an advisor with the Centre for Commercialization of Regenerative Medicine (CCRM) and she took time out of her busy schedule to sit down with CCRM and discuss what she sees as the future of regenerative medicine and commercializing the field.

Our regular feature, Right Turn, appears every Friday and we invite you to submit your own blog to info(at)ccrm.ca. We encourage you to be creative and use the right (!) side of your brain. We dare you to make us laugh! Right Turn features cartoons, photos, videos and other content to amuse, educate and encourage discussion.

As always, we welcome your feedback in the comment section.




The following two tabs change content below.
Stacey Johnson

Stacey Johnson

Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations since completing a MSc in Public Relations in 1997. Prior to that, Stacey was at the CTV Television Network, first as a researcher, then as a story producer for “Goldhawk Fights Back,” a special ombudsman segment that aired weekly on the National News and Canada AM. Before joining CCRM as the Director, Communications and Marketing, Stacey was the Director of Communications for the Canadian Arthritis Network. Stacey is editor of Signals. You can follow Stacey on Twitter @msstaceyerin.
Tags: , , , , ,

Leave a Reply